isoxazoles has been researched along with 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arindam, D; Baruchello, R; Benbrook, DM; Capone, F; D'Alessandro, N; Dusonchet, L; Grimaudo, S; Invidiata, FP; Landino, M; Lu, S; Malagutti, C; Mazzali, A; Meli, M; Raimondi, MV; Roberti, M; Rondanin, R; Rossi, M; Simoni, D; Tolomeo, M | 1 |
1 other study(ies) available for isoxazoles and 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid
| Article | Year |
|---|---|
Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.
Topics: Antineoplastic Agents; Apoptosis; Benzoates; Cell Differentiation; Cell Division; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Isoxazoles; Receptors, Retinoic Acid; Retinoids; Tetrahydronaphthalenes; Transcriptional Activation; Tumor Cells, Cultured | 2001 |